Net Cash Provided by (Used in) Financing Activities of Vaxart, Inc. from 25 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Vaxart, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 25 Dec 2010 to 31 Dec 2025.
  • Vaxart, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $164,000, a 101% decline year-over-year.
  • Vaxart, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $4,239,000, a 93% decline from 2024.
  • Vaxart, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $56,562,000, a 271% increase from 2023.
  • Vaxart, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $15,243,000, a 13% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Vaxart, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $4,239,000 -$52,323,000 -93% 01 Jan 2025 31 Dec 2025 10-K 13 Mar 2026 2025 FY
2024 $56,562,000 +$41,319,000 +271% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2026 2025 FY
2023 $15,243,000 -$2,219,000 -13% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $17,462,000 -$108,342,000 -86% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $125,804,000 -$12,510,000 -9% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $138,314,000 +$122,354,000 +767% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 $15,960,000 +$17,689,000 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $1,729,000 -$1,753,000 -7304% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $24,000 01 Jan 2017 31 Dec 2017 10-K 06 Feb 2019 2018 FY
2015 $100,000 -$26,900,000 -100% 01 Jul 2014 30 Jun 2015 10-K 11 Sep 2015 2015 FY
2014 $26,800,000 01 Jul 2013 30 Jun 2014 10-K 11 Sep 2015 2015 FY
2012 $400,000 -$1,063,000 -160% 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2014 2014 FY
2011 $663,000 +$48,841,000 26 Dec 2010 31 Dec 2011 10-K 14 Mar 2012 2011 FY
2010 $48,178,000 27 Dec 2009 25 Dec 2010 10-K 14 Mar 2012 2011 FY

Vaxart, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $164,000 -$18,359,000 -101% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $18,195,000 +$16,775,000 +1181% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $1,420,000 +$380,000 +37% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $1,040,000 -$66,552,000 -98% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $67,592,000 +$48,050,000 +246% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $19,542,000 +$17,419,000 +820% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $2,123,000 +$2,388,000 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q1 2018 $265,000 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q3 2015 $100,000 01 Jul 2015 30 Sep 2015 10-Q 06 Nov 2015 2016 Q1
Q1 2011 $295,000 26 Dec 2010 26 Mar 2011 10-Q 10 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.